Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 125
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in mice

An abundant ginger compound furanodienone alleviates gu...

 86

Habitual coffee intake shapes the gut microbiome and modifies host physiology and cognition

Habitual coffee intake shapes the gut microbiome and mo...

 39

Form follows function – structural interplay between DCL1 and pri-miRNAs

Form follows function – structural interplay between DC...

 398